Riskpilot← Back to searchSign inGet full accessKawa Asenger AB
ABBankruptOrg 5593310815Dental practice care activities · NACE 8623Est. 20210 employees
Revenue 2024
SEK 5,3M
+4% vs 2023
EBITDA margin
0.6%
-70% vs 2023
Equity ratio
0.5%
Financial strength
Net profit 2024
SEK -218K
-121% vs 2023
| Revenue | SEK 5,3M | +4% |
| EBITDA | SEK 33K | -70% |
| Net profit | SEK -218K | -121% |
| Total assets | SEK 4,6M | -2% |
| Equity | SEK 25K | -90% |
| Employees | 0 | — |
Legal name
Kawa Asenger AB
Org number
5593310815
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
19 augusti 2021
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva verksamhet inom skönhet och friskvård, tandvård, medicinsk vård och de farmakologiska yrkena samt bedriva relevant verksamhet inom vårdcentraler, sjukhus, apotek och tandvårdsenheter, bemanna med lämplig personal, importera, exportera, utveckla och handla med medicintekniska produkter samt idka därmed förenlig verksamhet och återinvestera i realkapital och fastigheter.
Address
Email
taher95@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 3 947 | 5 081 | 5 288 |
| Staff expenses | −1 456 | −2 259 | −2 469 |
| EBITDA | 727 | 112 | 33 |
| Depreciation & amort. | −342 | −208 | −236 |
| EBIT | 385 | −96 | −202 |
| Net financials | −0 | −2 | −15 |
| Profit before tax | 385 | −98 | −218 |
| Tax | −69 | — | — |
| Net profit | 316 | −98 | −218 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 4 464 | 4 637 | 4 567 |
| Equity | 341 | 243 | 25 |
| Long-term debt | 3 905 | 3 905 | 3 986 |
| Short-term debt | 218 | 489 | 556 |
| Total debt | 4 123 | 4 394 | 4 542 |
EBITDA margin
0.6%
This company
15.8%
Market median
-96% vs market
20222024
Equity ratio
0.5%
This company
38.2%
Market median
-99% vs market
20222024
Return on equity
-868.2%
This company
18.4%
Market median
-4818% vs market
20222024
Net profit margin
-4.1%
This company
8.1%
Market median
-151% vs market
20222024
Asset turnover
1.16×
This company
1.12×
Market median
+4% vs market
20222024
Debt / equity
181.09×
This company
0.62×
Market median
-29108% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
| Former (3) | ||
| Deputy Board Member | 2024 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kawa Asenger AB 
Bohuskliniken hud och kropp AB i StockholmBoard members of Kawa Asenger AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammad Mollazadegan | Board of Directors | 0 companies |
| Kaziwe Mollazadegan | Deputy Board Member | 0 companies |
| Leonardo Cave Mollazadegan | Board of Directors | 0 companies |
| Babak Rostamian | Deputy Board Member | 0 companies |